Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
Zachary J. Brown(National Institutes of Health), Su Jong Yu(National Institutes of Health), Bernd Heinrich(National Institutes of Health), Chi Ma(National Institutes of Health), Qiong Fu(National Institutes of Health), Milan Sandhu(National Institutes of Health), David Agdashian(National Institutes of Health), Qianfei Zhang(National Institutes of Health), Firouzeh Korangy(National Institutes of Health), Tim F. Greten(National Cancer Institute)
Cited by 111Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis